Dutch company offers its novel adjuvant for human therapeutic and infectious diseases vaccines

Dutch company that develops and exploits novel immune stimulants offers a license agreement for its human therapeutic and infectious diseases vaccines. They also participate in several EUROSTARS and HORIZON 2020 projects and seek for partners to discuss, write and submit collaborative grant applications. Potential partners operate in the field of vaccine research and development and want to develop and commercialize new vaccine products.
ACTIS Cooperación Empresarial
Enlace: Dutch company offers its novel adjuvant for human therapeutic and infectious diseases vaccines